Today, we start celebrating Pulmonary Rehabilitation Week. At Hexoskin, we think that Pulmonary Rehabilitation (PR) is vital and we are happy to celebrate all the efforts of the professionals and also the people who are following a PR. Pulmonary Rehabilitation programs have demonstrated health benefits and can positively improve the quality of life of people living with lung diseases.
If you have moderate to very severe Chronic obstructive pulmonary disease (COPD), you're probably eligible for pulmonary rehab. Ask your physician if there's a program near you.
For healthcare professionals, did you know that PR referrals & access are still very limited? According to a recent study, only 3% of Medicare beneficiaries with COPD are currently enrolled (Garvey et al. 2019). You can do your part by educating your peers, colleagues, and administrators about the benefits of PR.
For more information, visit the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) Website: https://www.aacvpr.org/Events-Education/Live-Workshops/Cardiac-Pulmonary-Rehabilitation-Weeks
#PRWeek20
This week is Pulmonary Rehabilitation Week! 🌬️🌬️🌬️
— Hexoskin - Sensors & AI (@Hexoskin) March 9, 2020
If you have moderate to very severe chronic obstructive pulmonary disease (COPD), you're probably eligible for pulmonary rehab. Ask your physician if there's a program near you.#PRWeek20https://t.co/4sjgq4eV0M
Hexoskin and Halo Health are announcing today a collaboration to solve key challenges in running clinical trials. Combining Hexoskin and Halo Health's technology will offer greater operational efficiency for virtual clinical trials and home monitoring, and offer tools to increase patient engagement.
These new tools will reduce the cost of collecting vital signs data for clinical trials, and will allow patients to participate in medical research from the comfort of their home.
Hexoskin smart garments and its Connected Health Platform are compatible with Halo Health solutions. The two companies will mutually promote their offering to pharmaceutical sponsors to support clinical development.
Halo Health is enabling patient-centric trials to reduce patient and site burden. Its Smart Clinical Trials solution is a digital health platform that provides Remote Patient Monitoring, Patient Engagement, and Workflow Automation. The solution includes an integrated ecosystem of clinical grade sensors and wearables to enable hybrid & virtual trials for various therapeutic areas including cardiology, respiratory and endocrinology.
Pierre-Alexandre Fournier - Chief Executive Officer at Hexoskin: “Medicine's progress depends on being able to better observe patients' outcomes. Anything we can do to lower the cost of data helps accelerate clinical development. This is something that Pharma and Biotech companies need to innovate, but most importantly this is something that we need to do to improve treatments for patients and find new cures for diseases that affect millions of people and their families.” says Pierre-Alexandre Fournier, Chief Executive Officer at Hexoskin. “Combining Halo Health's software with Hexoskin sensors and algorithms reduces the cost of collecting data in clinical trials, with greater flexibility & patient centricity.”
Hexoskin is a pioneer and leader in non-invasive vital signs sensors and remote patient monitoring solutions. Hexoskin Smart Clothing for Men, Women, and Children are clinically validated and its Connected Health Platform is used for health research in cardiology, pulmonology, psychiatry, rare diseases and many other health conditions.
We’re attending #DPHARM2019 in #Boston, at HaloHealth's Kiosk on September 17 & 18, 2019! Visit Booth 30 to learn about our joint innovative solutions to solve the key challenges of Clinical-trials!
Contact Hexoskin to learn more.
Montreal, Canada, August 22, 2019 - The CIHR (Canadian Institutes of Health Research) organized a press conference at CHU Sainte-Justine, Mother and Child University Hospital Center today to announce the funding of a five-year project to collect biological and vital signs data from patients suffering from Myalgic Encephalomyelitis (ME), also known as Chronic Fatigue Syndrome (CFS), to improve medical knowledge of the disease. Canadian Minister of Health, the Honourable Ginette Petitpas Taylor, was at the event to make the announcement with Dr. Alain Moreau, Scientific Director of the Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases.
In Canada, over half a million Canadians suffer from ME. According to the CDC (Center for Disease Control and Prevention), in the United States, 836,000 to 2.5 million Americans suffer from ME, but most of them have not been diagnosed. There is currently no biological diagnostic test for ME. The disease is diagnosed based on symptoms and by ruling out other conditions that could be causing the symptoms. The CHIR funded project will build the largest long-term cardiopulmonary and activity database in the world for patients with ME.
Hexoskin, a Montreal-based leader in smart clothing, health software, and AI services will provide its health monitoring solutions to support building the database. Pierre-Alexandre Fournier, CEO of Hexoskin, is pleased by today’s announcement: ‘’We believe this project will help us understand how to better take care of patients presenting symptoms of ME. Recent data shows that the prevalence of this disease is higher than previously estimated and has an enormous impact on Canadians living with ME and our society. Data collected in this project will impact millions of lives’’.
Dr. Alain Moreau will be the Principal Investigator with the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis - ICANCME - Research Network: “Myalgic Encephalomyelitis (ME) is possibly the last medical enigma of the 21st century. Our scientific partnership with Hexoskin will be instrumental to address the complexity of ME given its clinical heterogeneity and phenotypic variability overtime. The Hexoskin wearable technologies will allow researchers and clinicians to investigate people severely affected by ME (housebound or bedridden), which is rarely done due to their limited capacity to participate in clinical studies.”
Learn more on Health Research with Hexoskin.
To order, visit the Hexoskin Online Store or contact sales@hexoskin.com.
About Hexoskin:
Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. Hexoskin is an end-to-end system to monitor the user’s general health, vital signs, sleep, and activity, using built-in sensors embedded in Smart Garments made in Canada. The system can be used for a wide range of research domains including cardiology, respiratory, behavioural and physiological psychology, biofeedback, sleep patterns, circadian rhythms, effects of aging on physical performance, human energy expenditure, and physical conditioning.
The Hexoskin smart clothing and solutions were validated in over 250 scientific publications in the fields of cardiology, respiratory, behavioural and physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning. The company provides custom solutions, R&D project management, and services to international clients in defence, aerospace, security, police and first responders, pharmaceuticals, academics, and healthcare.
Hexoskin is also known for collaborating with the Canadian Space Agency to provide its advanced health technologies Astroskin (Bio-Monitor) to monitor the vital signs of the Canadian Astronaut David Saint-Jacques and future astronauts visiting in the International Space Station for the next five years. The company launched in 2018 the Astroskin platform for research and public/private projects on Earth.
Commuting by bike is a great way to include physical activity in our day-to-day living. However the impact of air pollution on cyclists is not something that is well understood.
Columbia University researchers Steven Chillrud, Darby Jack, and their colleagues from the Lamont-Doherty Earth Observatory have been using Hexoskin smart shirts and other sensors to collect data on pollution exposure in a real-world settings. This allows them to map pollution exposure around New York city. These maps can be used by cyclists and policy makers to better plan bike paths and bike lanes.
This project will have an important impact on urban design and mobility. Vice News covered their research project this week in this video:
Hexoskin will be in Minneapolis on October 16-19 to demonstrate its Hexoskin wearable health platform for remote patient monitoring and cardiac rehabilitation.
We're very excited to have been selected by Advamed as one of the world's top health innovation this year! Come see our presentation at the Innovation Showcase October 18 at 4pm to learn more about the advantages of using smart shirts remote patient monitoring and cardiac rehabilitation. Our CEO and Co-Founder Pierre-Alexandre Fournier will share our experiences working with patient populations affected by cardiac diseases and COPD.
Additionally, Hexoskin will demonstrate its technology in the exhibition hall of the conference on October 17-19 (room L100E/F in the partnering section downstairs). The Hexoskin team will present how Hexoskin can be used in clinical settings with live demos and presentations.
About Hexoskin
Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by space and defense agencies, sports scientists, and thousands of health professionals and health researchers all over the world. The Hexoskin connected platform provides a new, convenient way to understand human health in real-life environments. For more information, visit www.hexoskin.com and @Hexoskin on Twitter.
Disclaimer: Hexoskin smart shirts have not completed the FDA regulatory approval. Hexoskin products on the market as of October 2016 are not medical devices and shouldn't be used for diagnosis or therapeutic purposes. Hexoskin products on the market as of October 2016 are meant for wellness and fitness uses, and health research only.
This week Hexoskin is in Boston to attend the 3rd Annual Mobile in Clinical Trials on September 19th and the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials on September 20-21, 2016 in Boston. This annual event sponsored by Hexoskin is an opportunity for the Life Science industry to share the latest thinking, insights, and updates on the application of disruptive and mobile technologies to advance clinical research and drug development.
On September 20th, Pierre-Alexandre Fournier, CEO and Co-Founder of Hexoskin will present how clinical grade wearable sensors like Hexoskin is used for long-term remote monitoring in clinical trials. He will also share with the participants some use cases involving Hexoskin for monitoring patients in clinical research, and share lessons learned & best practices.
Additionally, Hexoskin will demonstrate its technology in the exhibition hall of the conference on September 20-21st (booth #35). The Hexoskin team will present how Hexoskin can be used in clinical development with live demos and presentations.
We're very excited to join world-class innovators at DPharm to discuss and reflect on how disruptive technologies like Hexoskin will change the landscape of clinical trials.
If you're in Boston come visit us on September 20-21st!
September 19, 2016: Mobile in Clinical Trials (Boston)
September 20-21, 2016: DPharm (Boston) - Disruptive Innovation to Advance Clinical Trials Conference
About Hexoskin
Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by space and defense agencies, sports scientists, and thousands of health professionals and health researchers all over the world, providing a new, convenient way to understand human health in real-life environments. For more information, visit www.hexoskin.com and @Hexoskin on Twitter.
The Free Flight Physiology Project Team in Karakorum, Pakistan is using Hexoskin to monitor their vitals when they fly over the countryside. Dr Matt Wilkes and this team from the Centre for Altitude, Space and Extreme Environment Medicine from the Institute of Sport Exercise & Heath (London, UK) are getting their gear ready for the Red Bull paragliding team later this year, but also to conduct serious research on physiology in altitude. They also took amazing pictures and video of their experience!
Here's more information about their project:
Because we recognize that sleep is a vital part of our lives, Hexoskin has made how we calculate your sleep metrics even more accurate. These improvements will allow you to have better insights on your slumber sessions.
Automatic detection is the key factor at play with our new Hexoskin sleep enhancements. The new server processing now automatically takes the device’s position into account when calculating your metrics.
View full article →
What a day! Today, we launched Hexoskin Smart, the first smart shirt compatible with popular fitness apps like Strava, Runkeeper, Endomondo, MapMyRun, and Runtastic, as well as devices like smartwatches, GPS watches, and bike computers on the popular crowdfunding site Indiegogo, just like we did in 2013 with Hexoskin Classic. Thanks to your help and support, we have been able to smash that goal within 12 hours of launching, and with over a month to go, we're counting on your support to break our previous Indiegogo record! Keep track of our progress and pre-order your Hexoskin Smart now at $299 ($100 off the future retail price) here: igg.me/at/hexoskin-smart.
View full article →
Wearable fans attending the Internet of Things (IoT) World Forum in Dubai, be sure to check out a live demo using Hexoskin as part of a health monitoring solution for the Dubai Police force, in the showcase until December 8th!
On Sunday December 6th, Cisco announced a partnership with Hexoskin, Davra Networks, and TCS to deliver a real-time police operations monitoring solution for the Dubai Police Force.
View full article →